News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Amol Akhade: Excited for the positive news on PFS for Destiny 09
Amol Akhade/LinkedIn
Apr 26, 2025, 00:17

Amol Akhade: Excited for the positive news on PFS for Destiny 09

Amol Akhade, Consultant Medical Oncologist and Hemato-oncologist at Suyog Cancer Clinics, shared a post on LinkedIn:

“Excited for the positive news on PFS for Destiny 09.

Any predictions on HR for PFS? ( my bet is on close to 0.5 for combination of Enhertu plus Pertuzumab)

The press release focuses on Enhertu plus Pertuzumab vs THP. Eagerly awaiting the complete dataset.”

Amol Akhade: Excited for the positive news on PFS for Destiny 09 Amol Akhade: Excited for the positive news on PFS for Destiny 09

Amol Akhade cancer OncoDaily Oncology
Special Coverage
Blog
May 16, 2025, 14:53
Tit Albreht Honored with Prestigious Inaugural Award for Improving Cancer Outcomes
Blog
May 16, 2025, 13:31
Anju Aledia: Exploring Science up Close with a Magnifying Glass
Blog
May 16, 2025, 13:24
Amil Družić: The European School of Oncology's Improving Cancer Outcomes and Leadership Course in Zagreb
Oncolibrary
May 16, 2025, 13:21
FDA Approves Retifanlimab-dlwr with Chemotherapy and as Monotherapy for Advanced Squamous Cell Carcinoma of the Anal Canal
Blog
May 16, 2025, 13:01
How Countries are Engaging Stakeholders in the Development and Implementation of NCCPs - Union for International Cancer Control
Oncolibrary
May 16, 2025, 12:59
Eating Well with Mesothelioma: What You Need to Know
Blog
May 16, 2025, 12:54
Douglas Flora: Fantastic Day Connecting with the Incredible Leaders at St. Elizabeth Healthcare
Blog
May 16, 2025, 12:37
Impact of Research Through Maggie’s Lung Cancer Journey - LUNGevity Foundation
Blog
May 16, 2025, 12:28
Giulio Draetta: A $150 million Gift from Kinder Foundation
Science
May 16, 2025, 12:19
Environmental Risk Factors of Wilms Tumour - Childhood Cancer and Leukemia International Consortium
Science
May 16, 2025, 12:17
ROSALINE Trial Reports 49% Response in Lobular Breast Cancer at ESMO 2025
Oncolibrary
May 16, 2025, 11:45
DESTINY-Breast06 Trial Updates at ESMO Breast 2025 Confirms T-DXd Efficacy in HER2-Low and Ultralow Metastatic Breast Cancer